BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 38764627)

  • 1.
    Zhang S; Huang L; Zeng Y; Gao G; Wu H; Li D; Guo R
    ACS Omega; 2024 May; 9(19):21116-21126. PubMed ID: 38764627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
    Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
    Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulated Solute Carrier Family 4 Member 4 Predicts Poor Progression in Colorectal Cancer.
    Yang H; Lu Y; Lan W; Huang B; Lin J
    J Cancer; 2020; 11(12):3675-3684. PubMed ID: 32284764
    [No Abstract]   [Full Text] [Related]  

  • 4. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
    Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
    Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
    Yang X; Wei W; Tan S; Guo L; Qiao S; Yao B; Wang Z
    World J Surg Oncol; 2021 Aug; 19(1):248. PubMed ID: 34419055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1.
    Zhang J; Wang Y; Hou S; Chi X; Ding D; Xue M; Zhang M; Wang J; Shuai J; Sun H; Gao Q; Kang C
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666541
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sałagacka-Kubiak A; Zawada D; Saed L; Kordek R; Jeleń A; Balcerczak E
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and Mechanism of Human ABC Transporters.
    Alam A; Locher KP
    Annu Rev Biophys; 2023 May; 52():275-300. PubMed ID: 36737602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of natural killer cells in innate immunity against colorectal cancer.
    Ghazvinian Z; Abdolahi S; Tokhanbigli S; Tarzemani S; Piccin A; Reza Zali M; Verdi J; Baghaei K
    Front Oncol; 2022; 12():1077053. PubMed ID: 36686835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel biallelic nonsense variant in SLC38A3 causing epileptic encephalopathy in an Indian family.
    Alawbathani S; Khan S; Westenberger A; Beetz C; Lingappa L
    Clin Genet; 2023 May; 103(5):609-611. PubMed ID: 36539921
    [No Abstract]   [Full Text] [Related]  

  • 11. The global, regional, and national burden and quality of care index (QCI) of colorectal cancer; a global burden of disease systematic analysis 1990-2019.
    Nejadghaderi SA; Roshani S; Mohammadi E; Yoosefi M; Rezaei N; Esfahani Z; Azadnajafabad S; Ahmadi N; Shahin S; Kazemi A; Namazi Shabestari A; Khosravi A; Mokdad AH; Larijani B; Farzadfar F
    PLoS One; 2022; 17(4):e0263403. PubMed ID: 35446852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIP4 targeted to recruit GTP-Cdc42 involving in invadopodia formation via NF-κB signaling pathway promotes invasion and metastasis of CRC.
    Hu Z; Zhu J; Ma Y; Long T; Gao L; Zhong Y; Wang X; Li Z
    Mol Ther Oncolytics; 2022 Mar; 24():873-886. PubMed ID: 35317515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Na
    Zhou X; Jiang M; Liu Z; Xu M; Chen N; Wu Z; Gu C; Chin E; Yang X
    J Oncol; 2021; 2021():3241351. PubMed ID: 34759967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biallelic variants in SLC38A3 encoding a glutamine transporter cause epileptic encephalopathy.
    Marafi D; Fatih JM; Kaiyrzhanov R; Ferla MP; Gijavanekar C; Al-Maraghi A; Liu N; Sites E; Alsaif HS; Al-Owain M; Zakkariah M; El-Anany E; Guliyeva U; Guliyeva S; Gaba C; Haseeb A; Alhashem AM; Danish E; Karageorgou V; Beetz C; Subhi AA; Mullegama SV; Torti E; Sebastin M; Breilyn MS; Duberstein S; Abdel-Hamid MS; Mitani T; Du H; Rosenfeld JA; Jhangiani SN; Coban Akdemir Z; Gibbs RA; Taylor JC; Fakhro KA; Hunter JV; Pehlivan D; Zaki MS; Gleeson JG; Maroofian R; Houlden H; Posey JE; Sutton VR; Alkuraya FS; Elsea SH; Lupski JR
    Brain; 2022 Apr; 145(3):909-924. PubMed ID: 34605855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-binding cassette (ABC) transporters in cancer: A review of recent updates.
    Wang JQ; Wu ZX; Yang Y; Teng QX; Li YD; Lei ZN; Jani KA; Kaushal N; Chen ZS
    J Evid Based Med; 2021 Sep; 14(3):232-256. PubMed ID: 34388310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of intestinal peptide transporter PEPT1 as a potential strategy for colorectal cancer sensitization.
    Wang Y; Wang J; Yang L; Qiu L; Hua Y; Wu S; Zeng S; Yu L; Zheng X
    Cell Death Dis; 2021 May; 12(6):532. PubMed ID: 34031358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance.
    Xiao H; Zheng Y; Ma L; Tian L; Sun Q
    Front Pharmacol; 2021; 12():648407. PubMed ID: 33953682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles of the solute carrier family in pancreatic cancer.
    Wu Z; Xu J; Liang C; Meng Q; Hua J; Wang W; Zhang B; Liu J; Yu X; Shi S
    Clin Transl Med; 2021 Mar; 11(3):e356. PubMed ID: 33783998
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.